Article
Cell Biology
Alexandra Neaverson, Malin H. L. Andersson, Osama A. Arshad, Luke Foulser, Mary Goodwin-Trotman, Adam Hunter, Ben Newman, Minal Patel, Charlotte Roth, Tristan Thwaites, Helena Kilpinen, Matthew E. Hurles, Andrew Day, Sebastian S. Gerety
Summary: Efficient and effective methods for converting human induced pluripotent stem cells into differentiated derivatives are critical for performing robust, large-scale studies of development and disease modelling, and for providing a source of cells for regenerative medicine. Here, we describe a 14-day neural differentiation protocol which allows for the scalable, simultaneous differentiation of multiple iPSC lines into cortical neural stem cells.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY
(2023)
Review
Biochemistry & Molecular Biology
Tianyuan Shi, Martin Cheung
Summary: Using rodents for modeling neurological diseases has limitations due to differences in genetics, neural development, and physiology between humans and rodents. In the past decade, induced pluripotent stem cells and induced neural stem cells generated through reprogramming somatic cells have offered a powerful alternative for studying disease pathogenesis and testing regenerative medicines. Urine-derived stem cells are an ideal cell source for reprogramming due to their proliferation, multipotency, epithelial nature, and ease of reprogramming.
CELL AND BIOSCIENCE
(2021)
Article
Biochemistry & Molecular Biology
David A. Yefroyev, Sha Jin
Summary: Neurodegenerative diseases are severe pathologies that affect cognitive ability, motor control, and everyday function. Pluripotent stem cell technology offers hope in addressing this problem, with induced pluripotent stem cells providing an alternative and endless source without the ethical and practical concerns of embryonic stem cells. This review focuses on iPSC technology, the pathophysiology of Alzheimer's and Parkinson's diseases, and current state-of-the-art approaches using iPSCs for treatment.
Article
Biochemistry & Molecular Biology
Bing-Chun Liu, Fang-Yuan Liu, Xin-Yue Gao, Yang-Lin Chen, Qiao-Qiao Meng, Yong-Li Song, Xi-He Li, Si-Qin Bao
Summary: The study reveals that Wnt signaling plays a crucial role in driving human pluripotent stem cells towards neural stem cells differentiation and maintaining their self-renewal. CLNSCs exhibit spinal cord properties and high proliferative capacity, providing a new cell model for investigating neurogenesis mechanisms and potential applications in regenerative medicine.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2021)
Review
Biochemistry & Molecular Biology
Yi-Ping Yang, Yu-Jer Hsiao, Kao-Jung Chang, Shania Foustine, Yu-Ling Ko, Yi-Ching Tsai, Hsiao-Yun Tai, Yu-Chieh Ko, Shih-Hwa Chiou, Tai-Chi Lin, Shih-Jen Chen, Yueh Chien, De-Kuang Hwang
Summary: Human pluripotent stem cells (PSCs) have the potential to replace diseased or injured tissues and are widely used in regenerative medicine. Induced pluripotent stem cells (iPSCs) can differentiate into various cell types and are being explored for the treatment of retinal diseases. Further clinical trials are needed to assess the efficacy and adverse effects of iPSC-based therapies.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2022)
Article
Cell Biology
Peng Cui, Ping Zhang, Lin Yuan, Li Wang, Xin Guo, Guanghui Cui, Yanmin Zhang, Minghua Li, Xiaowei Zhang, Xiaoqiang Li, Yuxin Yin, Zhendong Yu
Summary: HIF-1α knockdown affects the pluripotency and self-renewal potential of hiPSCs, promoting NSC differentiation and development potential possibly through the MFN2-mediated Wnt/beta-catenin signaling pathway.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY
(2021)
Review
Cell Biology
Yu Li, Ping-Ping Shen, Bin Wang
Summary: Spinal cord injury presents a significant challenge in trauma repair due to its difficulty and increasing morbidity. Stem cell therapy, particularly induced pluripotent stem cells, holds great potential in treating spinal cord injury by differentiating into precursor cells of various neural cell types at the injury site.
NEURAL REGENERATION RESEARCH
(2021)
Article
Biochemistry & Molecular Biology
Binna Seol, Young-Dae Kim, Yee Sook Cho
Summary: The study developed induced pluripotent stem cells and neural precursor cell models related to sialidosis, confirming their ability to faithfully recapitulate key disease-specific phenotypes. It was also found that impaired differentiation capacity of the cells could be effectively rescued by inducing autophagy.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2021)
Article
Medicine, Research & Experimental
Ruslan Rust, Rebecca Z. Weber, Melanie Generali, Debora Kehl, Chantal Bodenmann, Daniela Uhr, Debora Wanner, Kathrin J. Zuercher, Hirohide Saito, Simon P. Hoerstrup, Roger M. Nitsch, Christian Tackenberg
Summary: In this study, transgene- and xeno-free neural progenitor cells (NPCs) were generated for potential clinical applications. These cells had stable gene expression, could be expanded, and spontaneously differentiated into mature neurons. This research presents a valuable tool for safe and effective cell therapies for brain injuries.
JOURNAL OF TRANSLATIONAL MEDICINE
(2022)
Article
Cell & Tissue Engineering
Ana Belen Alvarez-Palomo, Jordi Requena-Osete, Raul Delgado-Morales, Victoria Moreno-Manzano, Carme Grau-Bove, Agueda M. Tejera, Manel Juan Otero, Carme Barrot, Irene Santos-Barriopedro, Alejandro Vaquero, Jovita Mezquita-Pla, Sebastian Moran, Carlos Hobeich Naya, Iris Garcia-Martinez, Francisco Vidal Perez, Maria A. Blasco, Manel Esteller, Michael J. Edel
Summary: The study demonstrates that utilizing synthetic mRNA transfection of CYCLIN D1 during reprogramming repairs DNA and significantly improves the genetic stability of human iPSC. This method reduces various genetic instabilities, decreases DNA damage, promotes correct protein expression, and reduces single-nucleotide polymorphism changes per chromosome.
Review
Pharmacology & Pharmacy
Lu Zhang, Xiao-Jing-Nan Ma, Yuan-Yuan Fei, Heng-Tong Han, Jun Xu, Lu Cheng, Xun Li
Summary: The liver has the ability to repair itself, but pathological changes can impair its regenerative capacity and lead to liver failure. Mesenchymal stem cells (MSCs) have shown promise in liver regeneration, and induced pluripotent stem cells have made progress in organoid establishment and drug screening.
PHARMACOLOGY & THERAPEUTICS
(2022)
Review
Cell & Tissue Engineering
Victoria Dupuis, Elisa Oltra
Summary: Mesenchymal stem cells (MSCs) have great potential for cell therapy due to their immunomodulatory effects, but their clinical application is restricted by several factors. Induced pluripotent stem cells (iPSCs) offer a new source to generate MSCs, known as iMSCs, which may overcome technical and biological limitations and ethical concerns regarding human embryonic stem cells. Various differentiation methods for iPSCs into MSCs have been developed to meet clinical demands.
WORLD JOURNAL OF STEM CELLS
(2021)
Article
Multidisciplinary Sciences
Panetha Pansri, Phetcharat Phanthong, Nopparat Suthprasertporn, Yindee Kitiyanant, Alisa Tubsuwan, Andras Dinnyes, Julianna Kobolak, Narisorn Kitiyanant
Summary: The study found that BDNF can promote cell proliferation of AD-derived hNPCs, but does not have a promoting effect on neurite outgrowth. The JAK2 inhibitor AG490 partially decreased BDNF-induced cell proliferation.
Review
Biotechnology & Applied Microbiology
Wei Cheng, Chengming Fan, Qing Song, Ping Chen, Hong Peng, Ling Lin, Cong Liu, Bin Wang, Zijing Zhou
Summary: Fibrotic diseases are responsible for a third of global deaths, leading to organ remodeling and dysfunction. Despite the complications of organ transplantation, induced pluripotent stem cell (iPSC)-based therapy shows potential as a treatment option by replacing fibrotic organs. Recent studies have successfully differentiated iPSCs into fibrosis-relevant cell types with anti-fibrotic effects, providing promising precision treatments for organ-specific fibrosis. This review summarizes the potential, advantages, challenges, and future outlook of iPSC-based approaches in treating organ fibrosis.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY
(2023)
Review
Immunology
Ratchapong Netsrithong, Methichit Wattanapanitch
Summary: This review discusses the current status and future directions of CAR T cell therapy, exploring the potential of using iPSCs as a source of T cells and the genome engineering techniques for generating next-generation CAR T cells. It also highlights the challenges faced at present and the prospects for future universal off-the-shelf immunotherapeutic products.
FRONTIERS IN IMMUNOLOGY
(2021)